Previously, we found a high level of expression of stem cell markers, CD133 and Oct3/4, and a high level of 8-oxodG in OV-CCA tissues, suggesting that stem cell mutations are involved in the inflammatory microenvironment during CCA development [35]. The gene discussed is PROM1; the disease is cholangiocarcinoma.